苑东生物
(688513)
| 流通市值：102.64亿 | | | 总市值：102.64亿 |
| 流通股本：1.77亿 | | | 总股本：1.77亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 810,266,206.25 | 496,753,707.66 | 971,404,996.5 | 585,013,271.79 |
| 交易性金融资产 | 730,156,846.48 | 996,189,770.91 | 452,351,434.46 | 824,184,373.74 |
| 应收票据及应收账款 | 211,016,627.28 | 194,299,523.99 | 195,078,970.92 | 250,937,841.62 |
| 其中：应收票据 | 18,932,630.09 | 16,876,170.5 | 17,611,940.35 | 17,897,555.07 |
| 应收账款 | 192,083,997.19 | 177,423,353.49 | 177,467,030.57 | 233,040,286.55 |
| 应收款项融资 | 22,312,692.96 | 59,906,022.51 | 93,359,802.44 | 70,795,231.84 |
| 预付款项 | 10,483,285.08 | 23,646,760.11 | 14,694,245.52 | 19,129,026.95 |
| 其他应收款合计 | 593,773.78 | 543,516.11 | 440,233.75 | 705,011.55 |
| 存货 | 216,531,218.89 | 213,618,891.26 | 190,086,164.97 | 184,327,814.13 |
| 其他流动资产 | 13,457,874.77 | 12,110,441.15 | 11,289,828.87 | 5,206,823.51 |
| 流动资产合计 | 2,014,818,525.49 | 1,997,068,633.7 | 1,928,705,677.43 | 1,940,299,395.13 |
| 非流动资产: | | | | |
| 长期股权投资 | 22,089,595.79 | 22,267,882.18 | 22,711,272.35 | 22,743,145.31 |
| 其他权益工具投资 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 其他非流动金融资产 | 48,000,000 | 48,000,000 | 48,000,000 | 48,000,000 |
| 固定资产 | 1,116,107,780.02 | 1,043,992,143.32 | 1,059,813,990.68 | 1,012,633,401.24 |
| 在建工程 | 112,190,863.23 | 202,364,335.46 | 189,555,095.28 | 242,891,290.89 |
| 无形资产 | 34,384,294.06 | 34,992,296.88 | 35,600,299.71 | 33,390,884.22 |
| 开发支出 | 76,784,835.06 | 74,522,745.76 | 73,765,361.82 | 68,207,182.78 |
| 长期待摊费用 | 3,153,912.84 | 3,437,693.71 | 3,743,744.05 | 3,698,124.3 |
| 递延所得税资产 | 10,164,165.33 | 12,359,877.22 | 11,503,748.44 | 11,951,943.47 |
| 其他非流动资产 | 14,809,462.01 | 11,839,737.81 | 16,728,310.84 | 24,398,075.99 |
| 非流动资产合计 | 1,447,684,908.34 | 1,463,776,712.34 | 1,471,421,823.17 | 1,477,914,048.2 |
| 资产总计 | 3,462,503,433.83 | 3,460,845,346.04 | 3,400,127,500.6 | 3,418,213,443.33 |
| 流动负债: | | | | |
| 短期借款 | 90,135,831.57 | 103,385,606.87 | 74,437,854.77 | 125,891,835.51 |
| 应付票据及应付账款 | 130,207,281.37 | 134,764,217.99 | 144,346,827.9 | 163,733,620.11 |
| 其中：应付票据 | 28,054,448.65 | 30,965,031.93 | 35,730,169.57 | 39,796,992.58 |
| 应付账款 | 102,152,832.72 | 103,799,186.06 | 108,616,658.33 | 123,936,627.53 |
| 合同负债 | 35,194,682.36 | 44,411,511.9 | 38,280,838.55 | 36,211,244.7 |
| 应付职工薪酬 | 31,054,896.13 | 24,766,413.7 | 57,448,412.4 | 38,217,113.12 |
| 应交税费 | 21,621,509.21 | 20,142,000.64 | 24,123,859.07 | 34,890,777.15 |
| 其他应付款合计 | 263,442,787.48 | 242,672,953.31 | 243,554,099.46 | 247,148,169.79 |
| 一年内到期的非流动负债 | 4,424,892.59 | 3,666,666.67 | 3,666,666.67 | 2,933,333.33 |
| 其他流动负债 | 5,736,981.61 | 19,617,497.76 | 10,460,475.84 | 13,546,308.62 |
| 流动负债合计 | 581,818,862.32 | 593,426,868.84 | 596,319,034.66 | 662,572,402.33 |
| 非流动负债: | | | | |
| 长期借款 | 33,733,333.32 | 35,961,768.32 | 35,933,333.32 | 38,160,140.74 |
| 递延收益 | 64,652,642.11 | 66,458,660.38 | 68,249,049.76 | 37,850,299.4 |
| 递延所得税负债 | 2,215,580.09 | 2,036,573.24 | 1,704,506.83 | 2,621,182.5 |
| 非流动负债合计 | 100,601,555.52 | 104,457,001.94 | 105,886,889.91 | 78,631,622.64 |
| 负债合计 | 682,420,417.84 | 697,883,870.78 | 702,205,924.57 | 741,204,024.97 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 176,532,256 | 176,532,256 | 176,532,256 | 176,532,256 |
| 资本公积 | 1,399,474,159.32 | 1,396,788,809.08 | 1,388,373,804.83 | 1,380,694,164.03 |
| 减:库存股 | 67,672,535.14 | 80,672,541.96 | 76,218,425.54 | 69,450,345.25 |
| 专项储备 | 1,758,693.53 | 1,512,355.08 | 1,023,695.32 | 2,233,659.54 |
| 盈余公积 | 79,462,430.94 | 79,462,430.94 | 79,462,430.94 | 60,045,000 |
| 未分配利润 | 1,190,528,011.34 | 1,189,338,166.12 | 1,128,747,814.48 | 1,126,954,684.04 |
| 归属于母公司股东权益合计 | 2,780,083,015.99 | 2,762,961,475.26 | 2,697,921,576.03 | 2,677,009,418.36 |
| 股东权益合计 | 2,780,083,015.99 | 2,762,961,475.26 | 2,697,921,576.03 | 2,677,009,418.36 |
| 负债和股东权益合计 | 3,462,503,433.83 | 3,460,845,346.04 | 3,400,127,500.6 | 3,418,213,443.33 |
| 公告日期 | 2025-08-19 | 2025-04-25 | 2025-04-25 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |